All Photon Counting CT Digests | 4 articles 4 categories

What's New in Photon Counting CT? — August 24, 2026

AI-summarised digest of 4 PubMed articles on Photon Counting CT published in the last 7 days.

What’s New in Photon Counting CT?

August 24, 2026 · 4 articles · 4 research themes · covering August 17, 2026 – August 24, 2026

Overview

Across these studies, photon-counting detector CT (PCD-CT) is repeatedly shown to improve diagnostic performance through spectral reconstruction and optimized image processing—often with the potential to simplify clinical workflows. In coronary CT angiography, a retrospective analysis suggests that routine sublingual nitroglycerin may not meaningfully improve diagnostic accuracy on photon-counting platforms, pointing toward protocol simplification and reduced nitrate exposure without loss of performance.

The remaining articles highlight the versatility of PCD-CT spectral techniques for tissue characterization and staging. Spectral reconstructions (virtual unenhanced images and iodine maps) improved differentiation of enhancing versus non-enhancing hyperdense adnexal lesions, which could reduce unnecessary follow-up. For bladder cancer, low-keV virtual monoenergetic images enhanced lesion-to-background contrast and improved detection of muscle invasion, supporting more accurate noninvasive staging. Finally, a feasibility study demonstrates that single-phase spectral black-blood CT using iodine suppression can enhance carotid vessel wall visualization, enabling clearer plaque-related feature assessment.

Overall, the dominant theme is that PCD-CT’s spectral capabilities—whether used to suppress iodine, generate virtual monoenergetic images, or create virtual unenhanced/iodine maps—are translating into more specific imaging biomarkers across multiple organ systems, with early evidence that these gains may reduce reliance on additional tests or complex protocols.


Photon-Counting CT for Coronary CT Angiography Protocol Optimization

Is nitroglycerin still necessary for coronary CT angiography in the era of photon-counting CT?

This retrospective single-center study evaluated whether sublingual nitroglycerin is still needed for diagnostic accuracy of photon-counting detector CT (PCD-CT) coronary CT angiography (CCTA) in 124 consecutive patients who also underwent invasive coronary angiography (ICA) within 30 days. The key finding was that nitroglycerin did not meaningfully improve diagnostic performance on PCD-CT CCTA compared with no nitroglycerin, indicating that its routine use may be unnecessary on photon-counting platforms. This matters clinically because omitting nitroglycerin could simplify CCTA protocols and reduce patient exposure to nitrates without sacrificing accuracy on newer PCD-CT systems.

Kabakus IM, Maisuria DM, Chamberlin JH et al. · Journal of cardiovascular computed tomography · (2026) · View on PubMed ↗ · Free PDF ↗


Photon-Counting CT Spectral Imaging for Gynecologic Lesion Characterization

Distinguishing enhancing from non-enhancing hyperdense adnexal lesions with spectral reconstructions at photon counting CT.

This retrospective study assessed whether photon-counting CT spectral reconstructions—specifically virtual unenhanced (VUE) and iodine map images—can distinguish enhancing from non-enhancing hyperdense adnexal lesions in adult women, using pelvic MRI or ultrasound within 180 days as the reference standard. The key finding was that spectral reconstructions from PCCT improved characterization of hyperdense adnexal lesions by separating iodine-enhancing lesions from non-enhancing ones more effectively than conventional CT alone. This is significant because it can reduce unnecessary follow-up imaging and improve triage of hyperdense adnexal findings using a noninvasive imaging approach.

Rigau D, Parrott D, Bansal B et al. · Abdominal radiology (New York) · (2026) · View on PubMed ↗


Photon-Counting CT for Bladder Cancer Staging (Muscle Invasion Detection)

Photon-Counting CT With Low-keV Virtual Monoenergetic Images for Detecting Muscle Invasion in Bladder Cancer: A Prospective Study.

In this prospective study, patients with pathologically confirmed bladder cancer underwent preoperative photon-counting detector (PCD) CT, comparing low-keV virtual monoenergetic images (VMIs at 40, 50, 60, and 70 keV) and T3D images against conventional polychromatic images for detecting muscle invasion. The key finding was that low-keV VMIs on PCD-CT improved performance for identifying muscle invasion compared with conventional polychromatic imaging, leveraging increased lesion-to-background contrast with acceptable noise. This is clinically important because more accurate noninvasive staging of bladder cancer can better guide treatment planning and potentially reduce reliance on invasive staging steps.

Wang W, He J, Wu J et al. · AJR. American journal of roentgenology · (2026) · View on PubMed ↗ · Free PDF ↗


Photon-Counting CT Spectral Black-Blood Imaging for Carotid Vessel Wall Assessment

Spectral Black-Blood Photon-Counting CT for High-Resolution Carotid Vessel Wall Imaging: A Feasibility Study.

This IRB-approved feasibility study used clinically indicated head-and-neck photon-counting detector (PCD) CT angiography data to generate a novel single-phase spectral black-blood CT (BBCT) reconstruction for high-resolution carotid vessel wall imaging, optimizing nine iodine ratio (IR) settings. The key finding was that spectral iodine suppression enabled effective intraluminal suppression while preserving vessel wall signal, supporting improved visualization of plaque-related features in carotid imaging. This is significant scientifically and potentially clinically because it demonstrates a practical pathway to higher-contrast carotid vessel wall imaging from a single-phase acquisition using photon-counting CT.

Tóth A, Hagar MT, Halfmann MC et al. · Investigative radiology · (2026) · View on PubMed ↗



Generated automatically on August 24, 2026. Covers PubMed articles published August 17, 2026 – August 24, 2026. Summaries are AI-generated; always consult the original publication for clinical or research decisions.